Towards Targeted Therapeutics: The Pharmaceutical Industry and Personalized Medicine
View more...
Imaginery Worlds: Reproducibility and Modeled Claims in Precision Medicine
View more...
Glimpsing the future: New immune-based therapies for multiple myeloma.
View more...
Prostate Cancer’s Precision Promise New research is revealing that the genetics of a man’s prostate tumor could dictate the treatments that will save his life
View more...
The mutual benefits of rare disease research and precision medicine
View more...
The Silent Epidemic of Alzheimer’s Disease: Can Precision Medicine Provide Effective Drug Therapies?
View more...
The Computational Network Imaging Frontier: Relevance for Digital Biomarkers in Precision Oncology.
View more...
Diagnosing rare disease
View more...
The Guardian Research Network: A Comprehensive Solution Supporting Adoption of Precision Medicine by the Community
View more...
Clinical Conundrums
View more...
Seracare Homepage 300dpi
New biomarker may identify multiple myeloma patients most likely to benefit from proteasome inhibitors

New biomarker may identify multiple myeloma patients most likely…

Houston, TX – Multiple myeloma is the second most common form of blood cancer, which develops from white blood cells in…

Read More...
Rare gene variants influence blood lipids and coronary artery disease risk

Rare gene variants influence blood lipids and coronary artery…

Reykjavik, Iceland – A dozen new, rare genetic variants that influence blood lipid levels have been identified by the…

Read More...
Antisense therapy for ALS/FTD a step closer to reality

Antisense therapy for ALS/FTD a step closer to reality

Charlestown MA and San Diego CA – A significant proportion of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia…

Read More...
Landmark study publishes definitive list of breast cancer mutations

Landmark study publishes definitive list of breast cancer mutations

Cambridge, UK – An international team of scientists, headquartered at the Wellcome Trust Sanger Institute in Cambridge,…

Read More...
SPARK becomes the US’s largest autism research study

SPARK becomes the US’s largest autism research study

Philadelphia PA – SPARK, an online research initiative with the aim of advancing understanding of the causes of autism…

Read More...
Dr. Stephen Kingsmore Sets Guinness World Records Title for Fastest Genetic Diagnosis

Dr. Stephen Kingsmore Sets Guinness World Records Title for…

SAN DIEGO, April 25, 2016 – Stephen Kingsmore, M.D., D.Sc., president and CEO of Rady Children’s Institute…

Read More...
Home Page Ad #2

Video

Precision Medicine at Notre Dame

Notre Dame building a premier precision medicine group...

Read More...

The Power of Research

Cancer Research UK - bringing the power of research to everyone...

Read More...

Value of Medical Innovation

Medical innovation is a virtuous cycle that relies on investments from all stakeholders, patient access to treatment, and…

Read More...

Biogen Idec is Biogen, Once Again

One of the original biotech companies, Biogen has been anchored in Cambridge, MA for nearly four decades. Today, we remain…

Read More...

Novartis Targets Cancer Genomics for Precision Medicine

Go behind the scenes of the Next Generation Diagnostics group at the Novartis Institutes for BioMedical Research, and learn…

Read More...

Early Diagnosis of Genetic Diseases

Parabase Genomics is a privately held molecular diagnostics company focused on changing the way newborns and children with…

Read More...

 Tweets

 Blogs

Real “health care” happens when telemedicine is closely joined to a connected-care delivery model...

What are the factors driving change within the Autoimmune Disease IVD market? Autoimmune diseases...

As scientific progression continues its march forward, the word ‘separation’ is something that we...

Home Page Ad #3